Cutler Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,400
Closed -$96K 6359
2021
Q4
$96K Buy
+3,400
New +$1.15M ﹤0.01% 1887
2019
Q3
Sell
-1,400
Closed -$5K 4903
2019
Q2
$5K Hold
1,400
﹤0.01% 3158
2019
Q1
$12K Buy
1,400
+500
+56% +$166K ﹤0.01% 2409
2018
Q4
$18K Sell
900
-300
-25% -$104K ﹤0.01% 2193
2018
Q3
$75K Buy
1,200
+100
+9% +$39.4K 0.01% 1364
2018
Q2
$48K Sell
1,100
-2,500
-69% -$906K ﹤0.01% 1641
2018
Q1
$44K Buy
+3,600
New +$912K ﹤0.01% 1752
2017
Q4
Sell
-3,500
Closed -$25K 6248
2017
Q3
$25K Sell
3,500
-700
-17% -$106K ﹤0.01% 2935
2017
Q2
$7K Buy
4,200
+1,300
+45% +$175K ﹤0.01% 4589
2017
Q1
$15K Sell
2,900
-11,900
-80% -$1.38M ﹤0.01% 3664
2016
Q4
$38K Sell
14,800
-9,300
-39% -$1.08M ﹤0.01% 2834
2016
Q3
$54K Buy
24,100
+10,200
+73% +$1.22M ﹤0.01% 2398
2016
Q2
$177K Buy
13,900
+1,700
+14% +$169K 0.01% 1208
2016
Q1
$105K Buy
12,200
+3,300
+37% +$279K 0.01% 1563
2015
Q4
$22K Buy
+8,900
New +$755K ﹤0.01% 3335

Other funds holding ABMD

Cutler Group's ABMD Position: Q1 2020 in Review

Cutler Group sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 1,900 shares — an estimated $315K sold.

Cutler Group first reported a position in ABMD in Q4 2015 and held it in 10 quarters. The position peaked at $1.02M in Q1 2016. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Cutler Group reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,900 Abiomed Inc shares in Q1 2020, an estimated $315K.
  • Cutler Group first reported a position in Abiomed Inc in Q4 2015 and held it in 10 quarters.
  • Cutler Group's Abiomed Inc position peaked at $1.02M in Q1 2016.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.